poisar

Stocks · News reference

Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil

Benzinga Newsdesk

Endovia Health Sciences, Inc. (NYSE:EDVA) ("Endovia" or the "Company"), an emerging cannabinoid-based health sciences company, today welcomed recent developments in the federal marijuana rescheduling

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

EDVA
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — Endovia Health Sciences, Inc. (EDVA)

    Filed: 2026-09-24 AccNo: 0001731122-26-001281 Size: 452 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

    EDVA